[Question] tirzepatide — what am I missing here
tirzepatide — what am I missing here. If this has been answered properly somewhere, link me and I will delete. Went 10 to 12.5 on the calendar and had the worst fortnight of the whole run. Dropped back to 10 and everything settled. Came off sema and onto tirz with a two-week gap. The first month was flat and I…
the appetite effect is blunter than sema, in a good way, most weeks
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads.
Not sure about this bit. The GIP arm being real does not tell you that it is what caused your particular week.
Not sure about this bit.
Saving this one. It is the clearest statement of the stall problem I have read here.
pens and vials are the same molecule, the price is the difference
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.
Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.
the trials titrated on a calendar, real people titrate on symptoms
hold the dose that works, the ladder is not a leaderboard